• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受己酸17-α-羟孕酮治疗的女性在妊娠小于34周因早产住院,她们可从每日围产期护理监测中获益。

Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance.

作者信息

Rittenberg Charles, Sullivan Scott, Istwan Niki, Rhea Debbie, Stanziano Gary, Newman Roger

机构信息

Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC, USA.

出版信息

Am J Obstet Gynecol. 2008 Oct;199(4):389.e1-4. doi: 10.1016/j.ajog.2008.06.070.

DOI:10.1016/j.ajog.2008.06.070
PMID:18928983
Abstract

OBJECTIVE

The objective of the study was to compare pregnancy outcomes of women receiving 17-alpha-hydroxyprogesterone caproate (17P) prophylaxis for the prevention of recurrent spontaneous preterm delivery (SPTD) hospitalized for preterm labor (PTL) less than 34 weeks' gestation prescribed daily vs weekly perinatal nursing surveillance.

STUDY DESIGN

Singleton gestations with prior SPTD enrolled for outpatient 17P administration at less than 27 weeks' gestation were eligible. Women hospitalized for PTL at less than 34 weeks (n = 379) were identified. Women receiving daily perinatal nursing surveillance (dPNS) (n = 99) following PTL were matched by Medicaid status and gestational age at onset of PTL to women receiving weekly surveillance (n = 280), yielding 83 matched pairs.

RESULTS

Among patients receiving 17P who were hospitalized for PTL, the addition of dPNS following hospitalization resulted in lower rates of SPTD less than 32 weeks (odds ratio [OR], 0.29, 95% confidence interval [CI], 0.21-0.38) and less than 35 weeks (OR, 0.25, 95% CI, 0.17-0.33), whereas the rates of SPTD less than 37 weeks were similar.

CONCLUSION

Women receiving prophylactic 17P hospitalized for PTL before 34 weeks benefit from the addition of daily perinatal nursing surveillance.

摘要

目的

本研究的目的是比较接受己酸17-α-羟孕酮(17P)预防复发性自发性早产(SPTD)的孕妇的妊娠结局,这些孕妇因妊娠小于34周的早产(PTL)住院,根据围产期护理监测情况每日或每周给药。

研究设计

纳入妊娠小于27周时登记门诊接受17P治疗的既往有SPTD的单胎妊娠者。确定妊娠小于34周因PTL住院的妇女(n = 379)。根据医疗补助状态和PTL发作时的孕周,将PTL后接受每日围产期护理监测(dPNS)的妇女(n = 99)与接受每周监测的妇女(n = 280)进行匹配,得到83对匹配组。

结果

在因PTL住院且接受17P治疗的患者中,住院后增加dPNS可降低小于32周(比值比[OR],0.29,95%置信区间[CI],0.21 - 0.38)和小于35周(OR,0.25,95% CI,0.17 - 0.33)的SPTD发生率,而小于37周的SPTD发生率相似。

结论

妊娠小于34周因PTL住院且接受预防性17P治疗的妇女,增加每日围产期护理监测有益。

相似文献

1
Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance.接受己酸17-α-羟孕酮治疗的女性在妊娠小于34周因早产住院,她们可从每日围产期护理监测中获益。
Am J Obstet Gynecol. 2008 Oct;199(4):389.e1-4. doi: 10.1016/j.ajog.2008.06.070.
2
The risk for preterm labor in women receiving 17 alpha-hydroxyprogesterone caproate prophylaxis for preterm birth prevention.接受 17α-羟孕酮己酸酯预防早产治疗的女性发生早产的风险。
Am J Perinatol. 2010 Apr;27(4):343-8. doi: 10.1055/s-0029-1243306. Epub 2009 Dec 10.
3
Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs. daily nursing surveillance.己酸17α-羟孕酮与每日护理监测预防早产的比较
J Reprod Med. 2009 Feb;54(2):47-52.
4
The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage.己酸17α-羟孕酮(17p)在宫颈环扎术女性中的应用。
Am J Perinatol. 2008 May;25(5):271-5. doi: 10.1055/s-2008-1064935. Epub 2008 Apr 9.
5
Influence of gestational age and reason for prior preterm birth on rates of recurrent preterm delivery.孕周和既往早产原因对复发性早产发生率的影响。
Am J Obstet Gynecol. 2011 Sep;205(3):275.e1-5. doi: 10.1016/j.ajog.2011.06.043. Epub 2011 Jun 17.
6
Recurrent preterm birth in women treated with 17 α-hydroxyprogesterone caproate: the contribution of risk factors in the penultimate pregnancy.接受己酸17α-羟孕酮治疗的女性复发性早产:倒数第二次妊娠中危险因素的作用。
J Matern Fetal Neonatal Med. 2012 Jul;25(7):1034-8. doi: 10.3109/14767058.2011.614657. Epub 2011 Oct 12.
7
17-alphahydroxyprogesterone caproate in women with previous spontaneous preterm delivery: does a previous term delivery affect the rate of recurrence?己酸羟孕酮治疗有自发性早产史的孕妇:是否足月分娩会影响复发率?
Am J Obstet Gynecol. 2011 Sep;205(3):269.e1-6. doi: 10.1016/j.ajog.2011.06.039. Epub 2011 Jun 17.
8
Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting.在社区环境中开具己酸17α-羟孕酮处方的女性的临床特征。
Am J Obstet Gynecol. 2007 Sep;197(3):262.e1-4. doi: 10.1016/j.ajog.2007.06.032.
9
Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery.己酸羟孕酮(17P)起始时的孕周与复发性早产
J Matern Fetal Neonatal Med. 2007 Mar;20(3):249-52. doi: 10.1080/14767050601152845.
10
The impact of maternal body mass on the effectiveness of 17 alpha-hydroxyprogesterone caproate.母体体重对己酸17α-羟孕酮有效性的影响。
J Reprod Med. 2008 Sep;53(9):667-71.

引用本文的文献

1
Risk assessment of preterm birth through identification and stratification of pregnancies using a real-time scoring algorithm.通过使用实时评分算法对妊娠进行识别和分层来评估早产风险。
SAGE Open Med. 2021 Jan 12;9:2050312120986729. doi: 10.1177/2050312120986729. eCollection 2021.